Treatment of endothelin-related disorders

Details Treatment of endothelin-related disorders Treatment of endothelin-related disorders

2007-08-14

2007-08-14

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Blood

C424S093700, C424S600000, C424S613000, C514S771000

Reexamination Certificate

active

10815509

ABSTRACT:
Endothelin-related disorders in mammals can be alleviated by administration to such patients of one or more aliquots of mammalian blood subjected to two or more stressors selected from temperature stressors, electromagnetic emissions and oxidative environments.

REFERENCES:
patent: 2002/0051766 (2002-05-01), Smith et al.
Sakai et al. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. JACC 1996, 28(6), 1580-1588.
Cooke et al. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. International Angiòlogy 1997, 16(4), 250-254.
MedlinePlus [online] Medical Encyclopedia: primary pulmonary hypertension [retrieved from the internet] Nov. 12, 2006, http://www.nlm.nih.gov/medlineplus/ency/article/000112.htm Feb. 1, 2005 pp. 1-2.
S. Babaei, D. J. Stewart, P. Picard, J.C. Monge, “Effects of VasoCare Therapy on the initiation and progression of aherosclerosis”, Atherosclerosis. 162 (2002) 45-53.

Affiliated with

Also associated with

Rating

Treatment of endothelin-related disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of endothelin-related disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of endothelin-related disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3833025